US 8785442
Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof
granted A61PA61P13/00A61P13/12
Quick answer
US patent 8785442 (Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof) held by Curegenix, Inc. expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Curegenix, Inc.
- Grant date
- Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P13/00, A61P13/12, A61P25/00, A61P31/00